Back to AMLX
Almitas Capital LLC AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$2.4M
Q3 2026
Peak value
$29.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $25.6M |
| Q1 2026 | $29.5M |
| Q2 2026 | $17.5M |
| Q3 2026 | $2.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.4M | 81.9K | — | — |
| Q2 2026 | $17.5M | 974.9K | — | — |
| Q1 2026 | $29.5M | 2.12M | — | — |
| Q4 2025 | $25.6M | 2.12M | — | — |
Other funds holding AMLX
$460.9M
$307.7M
$261.7M
$201.3M
$174.7M
$153.5M
Other Almitas Capital LLC positions
FBTC
$117.1MFIDELITY WISE ORIGIN BITCOIN
FBTC
$90.7MFIDELITY WISE ORIGIN BITCOIN
FBTC
$78.7MFIDELITY WISE ORIGIN BITCOIN
FBTC
$69.7MFIDELITY WISE ORIGIN BITCOIN
ASA
$42MASA GOLD AND PRECIOUS MTLS L
BSTZ
$33.9MBLACKROCK MUN TARGET TERM TR
BSTZ
$33.8MBLACKROCK MUN TARGET TERM TR
BSTZ
$33.7MBLACKROCK MUN TARGET TERM TR